These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 24560805)

  • 1. Evaluating prion models based on comprehensive mutation data of mouse PrP.
    Shirai T; Saito M; Kobayashi A; Asano M; Hizume M; Ikeda S; Teruya K; Morita M; Kitamoto T
    Structure; 2014 Apr; 22(4):560-71. PubMed ID: 24560805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-translational hydroxylation at the N-terminus of the prion protein reveals presence of PPII structure in vivo.
    Gill AC; Ritchie MA; Hunt LG; Steane SE; Davies KG; Bocking SP; Rhie AG; Bennett AD; Hope J
    EMBO J; 2000 Oct; 19(20):5324-31. PubMed ID: 11032800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The number of octapeptide repeat affects the expression and conversion of prion protein.
    Hiraga C; Kobayashi A; Kitamoto T
    Biochem Biophys Res Commun; 2009 May; 382(4):715-9. PubMed ID: 19318088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Introduction of glutamines into the B2-H2 loop promotes prion protein conversion.
    Avbelj M; Hafner-Bratkovič I; Jerala R
    Biochem Biophys Res Commun; 2011 Oct; 413(4):521-6. PubMed ID: 21910969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preventing misfolding of the prion protein by trimethylamine N-oxide.
    Bennion BJ; DeMarco ML; Daggett V
    Biochemistry; 2004 Oct; 43(41):12955-63. PubMed ID: 15476389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural features of prions explored by sequence analysis. II. A PrP(Sc) model.
    Mornon JP; Prat K; Dupuis F; Boisset N; Callebaut I
    Cell Mol Life Sci; 2002 Dec; 59(12):2144-54. PubMed ID: 12568340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. beta-sheet constitution of prion proteins.
    Ji HF; Zhang HY
    Trends Biochem Sci; 2010 Mar; 35(3):129-34. PubMed ID: 20060302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular dynamics of mouse and Syrian hamster PrP: implications for activity.
    Parchment OG; Essex JW
    Proteins; 2000 Feb; 38(3):327-40. PubMed ID: 10713992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toward a mechanism of prion misfolding and structural models of PrP(Sc): current knowledge and future directions.
    Guest WC; Plotkin SS; Cashman NR
    J Toxicol Environ Health A; 2011; 74(2-4):154-60. PubMed ID: 21218344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prion strain-dependent differences in conversion of mutant prion proteins in cell culture.
    Atarashi R; Sim VL; Nishida N; Caughey B; Katamine S
    J Virol; 2006 Aug; 80(16):7854-62. PubMed ID: 16873242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prion protein aggregation and fibrillogenesis in vitro.
    Stöhr J
    Subcell Biochem; 2012; 65():91-108. PubMed ID: 23225001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutation directional selection sheds light on prion pathogenesis.
    Shen L; Ji HF
    Biochem Biophys Res Commun; 2011 Jul; 410(2):159-63. PubMed ID: 21679685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The octarepeat region of the prion protein is conformationally altered in PrP(Sc).
    Yam AY; Gao CM; Wang X; Wu P; Peretz D
    PLoS One; 2010 Feb; 5(2):e9316. PubMed ID: 20195363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prion-protein-specific aptamer reduces PrPSc formation.
    Proske D; Gilch S; Wopfner F; Schätzl HM; Winnacker EL; Famulok M
    Chembiochem; 2002 Aug; 3(8):717-25. PubMed ID: 12203970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two-rung model of a left-handed beta-helix for prions explains species barrier and strain variation in transmissible spongiform encephalopathies.
    Langedijk JP; Fuentes G; Boshuizen R; Bonvin AM
    J Mol Biol; 2006 Jul; 360(4):907-20. PubMed ID: 16782127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toward the molecular basis of inherited prion diseases: NMR structure of the human prion protein with V210I mutation.
    Biljan I; Ilc G; Giachin G; Raspadori A; Zhukov I; Plavec J; Legname G
    J Mol Biol; 2011 Sep; 412(4):660-73. PubMed ID: 21839748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced sampling molecular dynamics identifies PrP(Sc) structures harboring a C-terminal β-core.
    Baillod P; Garrec J; Colombo MC; Tavernelli I; Rothlisberger U
    Biochemistry; 2012 Dec; 51(49):9891-9. PubMed ID: 23163312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding of neural cell adhesion molecules (N-CAMs) to the cellular prion protein.
    Schmitt-Ulms G; Legname G; Baldwin MA; Ball HL; Bradon N; Bosque PJ; Crossin KL; Edelman GM; DeArmond SJ; Cohen FE; Prusiner SB
    J Mol Biol; 2001 Dec; 314(5):1209-25. PubMed ID: 11743735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scrapie prion protein structural constraints obtained by limited proteolysis and mass spectrometry.
    Sajnani G; Pastrana MA; Dynin I; Onisko B; Requena JR
    J Mol Biol; 2008 Sep; 382(1):88-98. PubMed ID: 18621059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid interaction converts prion protein to a PrPSc-like proteinase K-resistant conformation under physiological conditions.
    Wang F; Yang F; Hu Y; Wang X; Wang X; Jin C; Ma J
    Biochemistry; 2007 Jun; 46(23):7045-53. PubMed ID: 17503780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.